Pharmacological basis and new insights of taxifolin: A comprehensive review
Autor: | Abhijit Das, Souvik Roy, Akash Kumar Samanta, Tania Chakraborty, Ratna Baidya |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Drug
Chemotherapeutics media_common.quotation_subject Disease RM1-950 Health benefits Phytochemical Bioinformatics Antioxidants chemistry.chemical_compound Neoplasms Anti-inflammation medicine Taxifolin Animals Humans media_common Randomized Controlled Trials as Topic Pharmacology Flavonoids business.industry Cancer General Medicine medicine.disease Antineoplastic Agents Phytogenic Cancer treatment chemistry Quercetin High incidence Therapeutics. Pharmacology Antioxidant business |
Zdroj: | Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112004-(2021) |
ISSN: | 0753-3322 |
Popis: | The pharmacological characteristics of phytochemicals have prompted a lot of interest in their application in disease management. Due to the high incidence of cancer related mortality and morbidity throughout the world; experiments have concentrated on identifying the anticancer potential of natural substances. Many phytochemicals such as flavonoids and their derivatives produced from food offer a variety of new anti-cancer agents which prevent the cancer progression. Taxifolin, a unique bioactive flavonoid, is a dietary component that has grabbed the interest of dietitians and medicinal chemists due to its wide range of health benefits. It is a powerful antioxidant with a well-documented effect in the prevention of several malignancies in humans. Taxifolin has shown promising inhibitory activity against inflammation, malignancies, microbial infection, oxidative stress, cardiovascular disease, and liver disease. Anti-cancer activity has been shown to be relatively significant than other activities investigated in vitro and in vivo with a little or no side effects to the normal healthy cells. In summary this review offers the synopsis of recent breakthroughs in the use of taxifolin as a cancer treatment, as well as mechanisms of action. However, to develop a medicine for human usage, more study on pharmacokinetic profile, profound molecular mechanisms, and drug safety criteria should be conducted utilizing well-designed randomized clinical trials. |
Databáze: | OpenAIRE |
Externí odkaz: |